Researchers have discovered that drugs like Ozempic for diabetes and obesity also improve alcohol use disorders and other addictions. This is a stunning gut-brain breakthrough.

There's no shortage of headlines and hypotheticals about the blockbuster drug class of GLP-1s. Stephen Klasko, MD, argues we're asking the wrong questions about GLP-1s. For health system leaders, the ...

LifeVantage expands its MindBody GLP-1 System™ internationally after notable U.S. revenue growth, targeting holistic wellness and metabolic health. LifeVantage Corporation is expanding its MindBody ...

Wegovy is now available in pill form. Are patches next?

As states cut Medicaid coverage for GLP-1 drugs, access to obesity treatment is increasingly tied to income—raising questions for both Medicaid and Medicare.

SoWell is unveiling GLP-1 Support System, a three-part supplement system designed specifically for GLP-1 users and their side effects. Alexandra Sowa, board-certified obesity medicine specialist, and ...

At Roxborough Memorial Hospital in Philadelphia, surgeon Piotr Krecioch has his hands full launching a program offering surgical interventions to treat obesity. One in three Philadelphians are living ...

Data analyses show that people with Type 2 diabetes using GLP-1 medicines saw a significant improvement in their HbA1C after adding FreeStyle Libre technology to their regimen Better HbA1c results ...

At Lifesum, we help organizations like Amazon, PayPal and GE, turn appetite changes into lasting habits through personalized ...

Experts at ISC 2026 highlighted growing evidence that GLP-1 receptor agonists may reduce stroke risk and support brain health through anti-inflammatory, vascular, and neuroprotective mechanisms.

GLP-1 drugs such as Ozempic and Mounjaro are a revolution, not a trend. These weight loss drugs are one of the hottest markets in healthcare, and there’s been a dramatic surge in the number of ...